Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells
about
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesisInterleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expressionTuning cell migration: contractility as an integrator of intracellular signals from multiple cuesFibronectin Interaction and Enhancement of Growth Factors: Importance for Wound HealingMechanochemical regulation of growth cone motilityαV integrins in angiogenesis and cancerCilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury modelPref-1 interacts with fibronectin to inhibit adipocyte differentiationThe extracellular matrix: not just pretty fibrilsHuman adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and deliveryHeparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergismPericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.Integrins as "functional hubs" in the regulation of pathological angiogenesisVitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney diseaseGene transcriptional networks integrate microenvironmental signals in human breast cancerProvisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.Biomaterials that regulate growth factor activity via bioinspired interactions.Overview of the matrisome--an inventory of extracellular matrix constituents and functionsA phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin.BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape.Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration.Vascular tube formation on matrix metalloproteinase-1-damaged collagenProtein-hydrogel interactions in tissue engineering: mechanisms and applications.Collagen IX is required for the integrity of collagen II fibrils and the regulation of vascular plexus formation in zebrafish caudal fins.Integrin and growth factor receptor alliance in angiogenesis.Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasionThe myofibroblast matrix: implications for tissue repair and fibrosis.Enter the matrix: shape, signal and superhighway.Vitronectin--master controller or micromanager?Assembly of human organs from stem cells to study liver disease.Fibronectin at select sites binds multiple growth factors and enhances their activity: expansion of the collaborative ECM-GF paradigm.An investigation into the stability of commercial versus MG63-derived hepatocyte growth factor under flow cultivation conditions.Towards integrating extracellular matrix and immunological pathways.Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors.Therapeutic potential of novel modulators of neovascularization.EDTA conditioning of dentine promotes adhesion, migration and differentiation of dental pulp stem cells.Biological assessment of a calcium silicate incorporated hydroxyapatite-gelatin nanocomposite: a comparison to decellularized bone matrix.
P2860
Q24318607-FC63AE68-B347-415E-89B6-93BE1C8EC9DBQ25257709-70B59381-984A-4FDD-8C55-34913422E378Q26742035-4A02C3A8-4C0A-4719-A362-A267C509E4A9Q26798456-AC6E22F8-95C4-4B60-B93D-DC4AF29CE32AQ26799030-E4110994-83F8-46A2-BBD5-C94271A9A747Q26851768-BC9F05B1-3A90-462E-AF83-E3CFFA2C9383Q28477044-6A2BFC48-0588-483C-8EBB-7E87FF786EFCQ28504692-FCE56EB9-6910-4112-9BBA-4999C045688CQ29617251-B5C0E61D-85F6-4557-BAAC-3558970F49EFQ30432578-B9CE8DF3-1F21-4436-8E58-1DAEA1522FB4Q30504482-84BF5A7D-44F4-47A8-9BD2-78255A0F9F3AQ33518855-41DECA6D-BD78-47AC-801C-1A6E272DF174Q33591910-28F816CC-4B9D-49D5-8E69-3493E6E01DDAQ34979663-AC98EA44-60A5-4AAB-B68C-38FFD36CD891Q35063558-9F4C783E-FC04-4BB6-BE76-13237D3CC669Q35156659-C279078A-829E-4A1C-83B9-A5E9E51BBFC5Q35208530-65A31D20-D139-4869-9845-09A7DDB1B531Q35645897-1966FF48-1F5D-4C2B-BEAC-4D768C585D2BQ35747034-FBF466EB-4AAE-4D48-9436-FB1E0ED5333FQ35951527-A34A6954-7305-42AE-9796-33F8DDBD5A83Q36148498-F53BE3FF-9741-4363-BAF5-61FA4C7916D7Q36289114-7679D3F4-5A33-432E-8541-C350D40A6946Q36489766-55068FF3-7129-4413-8E15-E64872859F9CQ36508636-EF81B6DD-4B0C-4941-A815-D4F9BA54DACAQ36667461-6BAE6455-BEFB-40BD-8479-BF915C131222Q36668673-3EA67132-4D2D-4656-914A-EFFD9F752831Q36949466-98187FDD-3D60-431C-A696-3A2AC1F64608Q37339044-8C7386AA-7B71-4700-BC71-8D76434D5A06Q37340100-BBEAA718-E0D5-4E04-96F5-2DF6BD2DAE20Q37733670-DEC7599C-942B-4D6B-AF5F-3B28336B37BBQ38078500-4EE86FB0-1814-4498-9DC0-EA6A01701791Q38137030-D2D27983-6D91-4773-9DA9-B27295426D81Q38170868-0010FC3F-76E2-495D-97F3-1A54B979C784Q38171137-FD0F830A-F86B-49DC-AAA1-5334C53B101FQ38946453-1F225862-CAD5-4920-BE6C-AEAA0D03EFA6Q39191612-E21D6374-8F27-43DE-93EE-A1CE9F43569BQ40018525-3DFF966E-B19D-4A3B-810A-1ADA50E7FB3FQ40076736-F0F9908B-416F-4F2B-901B-C762E8E2DE61Q40793973-8205BF09-1F1F-4478-B7A1-0F5050D300D2Q41824824-E3F751D3-E156-4AC6-BABC-4A76ECACCEFE
P2860
Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@ast
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@en
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@nl
type
label
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@ast
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@en
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@nl
prefLabel
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@ast
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@en
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@nl
P2093
P2860
P3181
P356
P1433
P1476
Novel hepatocyte growth factor ...... g pathway in endothelial cells
@en
P2093
Errol S Wijelath
Jacqueline Murray
Kirti V Patel
Michael Sobel
Rushika Sumathipala
Salman Rahman
Yatin Patel
P2860
P2888
P3181
P356
10.1186/1471-2121-6-8
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1050078407